Results 71 to 80 of about 52,371 (280)

Localised gastrointestinal diffuse large B cell lymphomas; Does surgical approach still exist?

Forum of Clinical Oncology, 2015
Background: Diffuse large B-cell lymphoma (DLBCL) is the commonest pathological type of gastrointestinal lymphoma and its management was changed from surgery to combined chemoimmunotherapy in the last decade; however, this strategy is questionable ...
Ibrahim Abeer, Zedan Ali, Attia Alia M. A.   +2 more
doaj   +1 more source

CD30 Expression and Its Correlation with Clinicopathologic Features in Indonesian Diffuse Large B-Cell Lymphoma

Asian Pacific Journal of Cancer Biology, 2020
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype (68.2%) of B cells Non Hodgkin Lymphoma in Indonesia. This tumor heterogeneity is characterized by a variety of clinical conditions, morphology, genetic profiles, therapeutic ...
Maria Reynelda Santoso, Mardiah Suci Hardianti, Indrawati Indrawati, Nungki Anggorowati   +3 more
doaj   +1 more source

LOOCV accuracy on the DLBCL dataset.

, 2015
LOOCV accuracy on the DLBCL dataset.
Saeid Nahavandi (714568), Abbas Khosravi (714566), Thanh Nguyen (253964), Douglas Creighton (714567)   +3 more
core   +1 more source

SENIOR‐IPI: An easily applicable prognostic index for first‐line large B‐cell lymphomas patients >80 years treated with curative intent

British Journal of Haematology, EarlyView.
Summary Using LYmphoma Study Association clinical trials combining 438 first‐line large B‐cell lymphomas (LBCL) patients >80 years old, we defined SENIOR‐IPI, an easily applicable prognostic index for this elderly population treated with an anti‐CD20‐miniCHOP (cyclophosphamide, doxorubicin, vincristine and prednisone)‐based regimen.
Sydney Dubois, Fanny Cherblanc, Aurelien Belot, Lucie Oberic, Hervé Ghesquières, Corinne Haioun, Hervé Tilly, Jean‐Philippe Jais, Fabrice Jardin   +8 more
wiley   +1 more source

Pie charts of STAT3 splice variants in DLBCL.

, 2015
Splice variant ratios in DLBCL differ minimally, except for RIVA. Absolute quantification qPCR was used to determine proportions of STAT3 splice variants in each cell line. Percentages of each splice variant are shown.
Douglas S. Annis (332951), Stephane Esnault (24104), Keren B. Turton (740649), Deane F. Mosher (330828), Lixin Rui (740650)   +4 more
core   +1 more source

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

British Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa, Marianne Brodtkorb, Sämi Schär, Björn E. Wahlin, Micaela Hernberg, Michael Pedersen, Anastasios Stathis, Thilo Zander, Urban Novak, Thorsten Zenz, Natalie Fischer, Fatime Krasniqi, Felicitas Hitz, Ann‐Sofie Johansson, David Löfgren, Peter Albert Meyer, Anne Turid Bjørnevik, Giulio Sartori, Stefanie Hayoz, Andrea Fuhrer, Luzia Steiner, Francesco Bertoni, Luca Ceriani, Stefan Dirnhofer, Emanuele Zucca, Bjørn Østenstad   +25 more
wiley   +1 more source

Transcriptomics-Based Investigation of Molecular Mechanisms Underlying Apoptosis Induced by ZnO Nanoparticles in Human Diffuse Large B-Cell Lymphoma

International Journal of Nanomedicine, 2022
Suliman A Alsagaby Department of Medical Laboratories Sciences, College of Applied Medical Sciences, Majmaah University, AL-Majmaah, 11932, Saudi ArabiaCorrespondence: Suliman A Alsagaby, Email s.alsaqaby@mu.edu.saIntroduction: Zinc oxide nanoparticles ...
Alsagaby SA
doaj  

MTDH is overexpressed in DLBCL tumor samples.

, 2012
(A) Real-time quantitative PCR analysis of MTDH expression in DLBCL (n = 21) and control (n = 25). PCR products were confirmed as a single product at the desired size on agarose gels (1–3: DLBCL; 4–5: Control). Control, reactive hyperplasia of lymph node.
Xiao Lv (154278), Lili Feng (154280), Na Chen (153323), Xiaoqian Liu (154284), Junming Gao (154287), Xin Wang (91924), Xueling Ge (154276)   +6 more
core   +1 more source

Clinical characteristics of DLBCL datasets(GSE10846 and GSE31312).

, 2023
Clinical characteristics of DLBCL datasets(GSE10846 and GSE31312).
Chengcheng Liao (12402943), Dani Zhong (17427551), Qing Ke (577483), Shengjuan Lu (17427545), Sha He (1514137), Xiaoxun Xie (17427554), Hong Cen (577481), Guojun Mo (2244643), Chao Rong (2032945), Xiaohong Tan (485470), Danqing Lei (816215), Yuanhong Li (2414860), Guodi Ou (17427548), Lin Zeng (161089), Hailian Wu (10688266), Jie Sun (74648), Qingmei Zhang (14200580)   +16 more
core   +1 more source